Evidence map›Paper›PMID 32314734›Full record

ArticleeLife2020

Dual orexin and MCH neuron-ablated mice display severe sleep attacks and cataplexy.

Chi Jung Hung, Daisuke Ono, Thomas S Kilduff, Akihiro Yamanaka

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Neurotensin in the extended amygdala maintains wakefulness in novel environments.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Review
  4. Neuropeptidergic Input from the Lateral Hypothalamus to the Suprachiasmatic Nucleus Alters the Circadian Period in Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  5. Review
  6. Article
  7. Insomnia-related rodent models in drug discovery.Acta pharmacologica Sinica · 2024
    Review
  8. Neural Control of REM Sleep and Motor Atonia: Current Perspectives.Current neurology and neuroscience reports · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. An excitatory peri-tegmental reticular nucleus circuit for wake maintenance.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Conditional Knockout ofFrontiers in neuroscience · 2021
    Article
  19. Mapping Network Activity in Sleep.Frontiers in neuroscience · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Chi Jung Hung *Department of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.ORCID 0000-0002-1169-7953
Daisuke Ono *Department of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.ORCID 0000-0001-5967-2002
Thomas S KilduffCenter for Neuroscience, Biosciences Division, SRI International, Menlo Park, United States.ORCID 0000-0002-6823-0094
Akihiro YamanakaDepartment of Neuroscience II, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan.ORCID 0000-0001-6099-7306
Japan Science and Technology Agency · JPSRI International · US

Funding

U.S.-Japan BRCP Supplement to "The Tuberal Hypothalamus and Arousal State Control"R01NS098813 · NINDS · SRI INTERNATIONAL · PI KILDUFF, THOMAS S · 2016 to 2020
$3.3M
Japan Science and Technology Agency JPMJCR1656Ministry of Education, Culture, Sports, Science and Technology 16H01271Ministry of Education, Culture, Sports, Science and Technology 17H05563Ministry of Education, Culture, Sports, Science and Technology 18H02477Ministry of Education, Culture, Sports, Science and Technology 18H02523Ministry of Education, Culture, Sports, Science and Technology 18H05124Ministry of Education, Culture, Sports, Science and Technology 18KK0223Ministry of Education, Culture, Sports, Science and Technology 26293046Ministry of Education, Culture, Sports, Science and Technology 26640041NINDS NIH HHS R01 NS098813
6 · The paper itself

Abstract

Orexin/hypocretin-producing and melanin-concentrating hormone-producing (MCH) neurons are co-extensive in the hypothalamus and project throughout the brain to regulate sleep/wakefulness. Ablation of orexin neurons decreases wakefulness and results in a narcolepsy-like phenotype, whereas ablation of MCH neurons increases wakefulness. Since it is unclear how orexin and MCH neurons interact to regulate sleep/wakefulness, we generated transgenic mice in which both orexin and MCH neurons could be ablated. Double-ablated mice exhibited increased wakefulness and decreased both rapid eye movement (REM) and non-REM (NREM) sleep. Double-ablated mice showed severe cataplexy compared with orexin neuron-ablated mice, suggesting that MCH neurons normally suppress cataplexy. Double-ablated mice also showed frequent sleep attacks with elevated spectral power in the delta and theta range, a unique state that we call 'delta-theta sleep'. Together, these results indicate a functional interaction between orexin and MCH neurons in vivo that suggests the synergistic involvement of these neuronal populations in the sleep/wakefulness cycle.

Indexed as

Hypothalamic HormonesMelaninsOrexinsPituitary HormonesAnimalsCataplexyMiceMice, TransgenicNeuronsSleepWakefulnessHypothalamic Hormonesmelanin-concentrating hormoneMelaninsOrexinsPituitary Hormonesablationmch neuronsmousenarcolepsyneuroscienceorexin/hypocretin neuronssleeptransgenic animals

Identifiers

PMID32314734
PMCPMC7173968
OpenAlexW3016276625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.